Shimizu Y, Iwatsuki S, Herberman R B, Whiteside T L
Pittsburgh Cancer Institute, PA.
Int J Cancer. 1990 Nov 15;46(5):878-83. doi: 10.1002/ijc.2910460521.
Phenotypic and functional characteristics of tumor-infiltrating lymphocytes (TIL) obtained from human primary and metastatic liver tumors were studied. Lymphocytes isolated from 18 tumors and autologous (A) peripheral blood (6 cases) were phenotyped by 2-color flow cytometry and cloned in a limiting dilution system, which allows virtually all normal T lymphocytes to proliferate; 70-80% of fresh TIL were T cells (i.e., CD3+), and the ratio of CD4+/CD8+ cells was 1.2 in both primary and metastatic liver tumors. TIL contained significantly more CD56+ (NKHI+) cells, half of which were CD3+CD56+, CD3+CD25+ cells and CD3+HLA-DR+ cells, than A-PBL. The frequencies of proliferating T-cell precursors (PTL-p) and cytolytic T-lymphocyte precursors (CTL-p) reactive with K562, allogeneic tumor cells and autologous tumor cells, were determined. Mean PTL-p frequencies for TIL from hepatocellular carcinomas, cholangiocarcinomas and metastatic liver tumors were 0.52 (0.22-0.83), 0.10 (0.05-0.16) and 0.16 (0.01-0.30), respectively. The frequency of CTL-p with natural-killer-like activity was lower in TIL than in A-PBL. The frequency of CTL-p for autologous tumor cells in fresh TIL isolated from primary liver tumors was 0.02-0.13 and 12/81 clones were reactive against autologous tumor. In contrast, only 1/66 TIL clones obtained from colon carcinomas metastatic to liver showed autotumor reactivity. No clones reactive with autologous tumor were obtained from peripheral blood of patients with liver cancer. These data indicate that substantial differences in anti-tumor functions of TIL between primary and metastatic liver tumors exist, which can be detected at a clonal level.
对从人类原发性和转移性肝肿瘤中获取的肿瘤浸润淋巴细胞(TIL)的表型和功能特征进行了研究。从18个肿瘤和自体(A)外周血(6例)中分离出的淋巴细胞通过双色流式细胞术进行表型分析,并在有限稀释系统中进行克隆,该系统几乎能使所有正常T淋巴细胞增殖;70 - 80%的新鲜TIL是T细胞(即CD3 +),原发性和转移性肝肿瘤中CD4 + / CD8 +细胞的比例均为1.2。与A - PBL相比,TIL中CD56 +(NKHI +)细胞显著更多,其中一半是CD3 + CD56 +、CD3 + CD25 +细胞和CD3 + HLA - DR +细胞。测定了与K562、同种异体肿瘤细胞和自体肿瘤细胞反应的增殖性T细胞前体(PTL - p)和细胞毒性T淋巴细胞前体(CTL - p)的频率。来自肝细胞癌、胆管癌和转移性肝肿瘤的TIL的平均PTL - p频率分别为0.52(0.22 - 0.83)、0.10(0.05 - 0.16)和0.16(0.01 - 0.30)。具有自然杀伤样活性的CTL - p频率在TIL中低于A - PBL。从原发性肝肿瘤分离的新鲜TIL中针对自体肿瘤细胞的CTL - p频率为0.02 - 0.13,12 / 81个克隆对自体肿瘤有反应。相比之下,从转移至肝脏的结肠癌中获得的TIL克隆中只有1 / 66显示出对自体肿瘤的反应性。从肝癌患者外周血中未获得与自体肿瘤反应的克隆。这些数据表明,原发性和转移性肝肿瘤之间TIL的抗肿瘤功能存在实质性差异,这可以在克隆水平上检测到。